Kyverna Therapeutics Inc. Watch

from S-8 7 pages Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan Restricted Stock Unit Agreement

from S-8 9 pages Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan Stock Option Agreement

from 8-K 7 pages November 8, 2024 in Person and via Email Dr. James Chung Dear James: This Letter (The “Agreement”) Sets Forth the Terms and Conditions of Your Separation From Kyverna Therapeutics, Inc. (The “Company”) in Connection With Your Termination of Employment. 1

from 8-K 14 pages Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan

from 8-K 9 pages 1. Separation. as a Result of Your Voluntary Resignation, Your Last Day of Work With the Company and Your Employment Termination Date Was September 13, 2024 (The “Separation Date”). You Agree That, Effective as of the Separation Date, You Have Resigned From (A) All Positions That You Held With the Company or Any of Its Subsidiaries and Affiliates, Including, Without Limitation, as an Employee, Officer, Manager or Director and (B) All Fiduciary Positions (Including as a Trustee) You Held With Respect to Any Employee Benefit Plans or Trusts Established by the Company or Any Affiliate, and You Hereby Confirm That Your Resignation Was Not Due to Any Disagreement With the Company Relating to Any of the Company’s Operations, Policies or Practices. You Agree to Execute Any Additional Documents Consistent With the Foregoing Resignations That the Company May Reasonably Request

from 8-K 16 pages September 14, 2024 Warner Biddle via Email Re: Employment Terms Position

from S-8 12 pages Kyverna Therapeutics, Inc. 2024 Employee Stock Purchase Plan Adopted by the Board of Directors: January 24, 2024 Approved by the Stockholders: January 30, 2024 Ipo Date: February 7, 2024

from S-8 22 pages Kyverna Therapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: January 24, 2024 Approved by the Stockholders: January 30, 2024 Ipo Date: February 7, 2024

from S-1/A 4 pages Kyverna Therapeutics, Inc. Rsu Award Grant Notice

from S-1/A 4 pages Kyverna Therapeutics, Inc. Non-Employee Director Compensation Program

from S-1/A 18 pages Indemnification and Advancement Agreement

from S-1/A 12 pages Kyverna Therapeutics, Inc. 2024 Employee Stock Purchase Plan Adopted by the Board of Directors: January 24, 2024 Approved by the Stockholders: January 30, 2024 Ipo Date: [●], 2024

from S-1/A 4 pages Kyverna Therapeutics, Inc. Restricted Stock Award Grant Notice

from S-1/A 6 pages Kyverna Therapeutics, Inc. Stock Option Grant Notice

from S-1/A 23 pages Kyverna Therapeutics, Inc. 2024 Equity Incentive Plan Adopted by the Board of Directors: January 24, 2024 Approved by the Stockholders: January 30, 2024 Ipo Date: [●], 2024

from S-1 30 pages ***Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) of the Type That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[…***…]”) in This Exhibit.*** Public Health Service Patent License Agreement – Exclusive

from S-1 29 pages ***Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) of the Type That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[…***…]”) in This Exhibit.*** Public Health Service Patent License Agreement – Exclusive

from S-1 104 pages ***Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) of the Type That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[…***…]”) in This Exhibit.*** License and Collaboration Agreement by and Between Kyverna Therapeutics, Inc. and Intellia Therapeutics, Inc. December 29, 2021

from S-1 11 pages First Amendment

from S-1 99 pages Office/Laboratory Lease Between Emery Station Office II, LLC (Landlord) and Kyverna Therapeutics, Inc. (Tenant) 5980 Horton Street Emeryville, California